Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo

Journal of Neurochemistry

Volumn 113, Issue 1, 2010, Pages 228-235

  Hewett, Jeff ^a   Johanson, Peter ^a   Sharma, Nutan ^a   Standaert, David ^b   Balcioglu, Aygul ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Dopamine; DYT1 dystonia; Locomotion; Mouse; No net flux microdialysis; Striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; NOMIFENSINE; PROTEIN; TORSINA; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOMEGALOVIRUS; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; EARLY ONSET TORSION DYSTONIA; IN VIVO STUDY; LOCOMOTION; MICRODIALYSIS; MOLECULAR PROBE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STRAIN DIFFERENCE; TASK PERFORMANCE; TORSION DYSTONIA; TRANSGENIC ANIMAL; WILD TYPE;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; HUMANS; LINEAR MODELS; MICE; MICE, TRANSGENIC; MICRODIALYSIS; MOLECULAR CHAPERONES; MOTOR ACTIVITY; MUTATION; NOMIFENSINE;

ANIMALIA; CYTOMEGALOVIRUS; MUS; MUS MUSCULUS;

EID: 77749271032     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06590.x     Document Type: Article

References (53)

1. 2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64, 347 349.
2. Augood S. J., Martin D. M., Ozelius L. J., Breakfield X. O., Penney J. B. Standaert D. G. (1999) Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 46, 761 769.
3. Augood S. J., Hollingsworth Z., Albers D. S., Yang L., Leung J., Breakefield X. O. Standaert D. G. (2004) Dopamine transmission in DYT1 dystonia. Adv. Neurol. 94, 53 60.
4. Balcioglu A., Zhang K. Tarazi F. I. (2003) Dopamine depletion abolishes apomorphine and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats. A microdialysis study. Neuroscience 119, 1045 1053.
5. Balcioglu A., Kim M. O., Sharma N., Cha J. H., Breakefield X. O. Standaert D. G. (2007) Dopamine release impaired in a mouse model of DYT1 dystonia. J. Neurochem. 102, 783 788.
6. Chefer V. I., Czyzyk T., Bolan E. A., Moron J., Pintar J. E. Shippenberg T. S. (2005) Endogenous κ-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J. Neurosci. 25, 5029 5037.
7. Dang M. T., Yokoi F., McNaught K. S. P., Jengelley T. A., Jackson T., Li J. Li Y. (2005) Generation and characterization of Dyt1 ΔGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452 463.
8. Dang M. T., Yokoi F., Pence M. A. Li Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56, 470 474.
9. Ellgaard L. Helenius A. (2003) Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4, 181 191.
10. Farhan H., Freissmuth M. Sitte H. H. (2006) Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. Handb. Exp. Pharmacol. 175, 233 249.
11. Franklin K. B. Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, Burlington, MA.
12. Giros B., Jaber M., Jones S. R., Wrightman R. M. Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606 612.
13. Goodchild R. E., Kim C. E. Dauer W. T. (2005) Loss of the dystonia associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48, 923 932.
14. Grundmann K., Reischmann B., Vanhoutte G., et al. (2007) Overexpression of human wild-type torsinA and human ΔGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 27, 190 206.
15. Hewett J., Gonzalez-Agosti C., Slater D., Ziefer P., Li S., Bergeron D., Jacoby D. J., Ozelius L. J., Ramesh V. Breakefield X. O. (2000) Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum. Mol. Genet. 9, 1403 1413.
16. Hewett J. W., Tannous B., Niland B. P., Nery F. C., Zeng J., Li Y. Breakefield X. O. (2007) Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc. Natl Acad. Sci. USA 104, 7271 7276.
17. Ichinose H., Ohye T., Takahashi E. et al. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 8, 236 242.
18. Jankovic J. Fahn S. (1993) Dystonic disorders, in Parkinson's Disease and Movement Disorders (Jankovic J. Tolosa E., eds pp. 337 374. Williams and Wilkins, Baltimore, MD.
19. Jones S. R., Garris P. A. Wightman R. M. (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396 403.
20. Jones S. R., Gainetdinov R. R., Wightman R. M. Caron M. G. (1998a) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979 1986.
21. Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. Caron M. G. (1998b) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. USA 95, 4029 4034.
22. Justice J. B. (1993) Quantitative microdialysis of neurotransmitters. J. Neurosci. Methods 48, 263 276.
23. Knappskog P. M., Flatmark T., Mallet J., Ludecke B. Bartholome K. (1995) Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 1209 1212.
24. Koh Y. H., Rehfeld K. Ganetzky B. (2004) A Drosophila model of early onset torsion dystonia suggests impairment in TGF-beta signaling. Hum. Mol. Genet. 13, 2019 2030.
25. Kuczenski R. Segal D. S. (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085 1094.
26. Kuczenski R., Segal D. S., Cho A. K. Melega W. (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15, 1308 1317.
27. Kustedjo K., Bracey M. H. Cravatt B. F. (2000) Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J. Biol. Chem. 275, 27933 27939.
28. Liu Z., Zolkiewska A. Zolkiewska M. (2003) Characterization of human torsinA and its dystonia-associated mutant form. Biochem. J. 374, 117 122.
29. Lupas A., Flanagan J. M., Tamura T. Baumeister W. (1997) Self-compartmentalization proteases. Trends Biochem. Sci. 22, 399 404.
30. McNaught K. S., Kapustin A., Jackson T., Jengelley T. A., Jnobaptiste R., Shashidharan P., Perl D. P., Pasik P. Olanow C. W. (2004) Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 56, 540 547.
31. Misbahuddin A., Placzek M. R., Taanman J. W., Gschmeissner S., Schiavo G., Cooper J. M. Warner T. T. (2005) Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Disord. 20, 432 440.
32. Morón J. A., Brockington A., Wise R. A., Rocha B. A. Hope B. T. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389 395.
33. Neuwald A. F., Aravind L., Spouge J. L. Koonin E. V. (1999) AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 27 43.
34. Ogura T. Wilkinson A. J. (2001) AAA+ superfamily ATPases: common structure - diverse function. Genes Cells 6, 575 597.
35. Orset C., Parrot S., Sauvinet V., Cottet-Emard J. M., Bérod A., Pequignot J. M. Denoroy L. (2005) Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis. Neurochem. Int. 46, 623 633.
36. Ozelius L. J., Hewett J., Page C. et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17, 40 48.
37. Piazza P. V., Deminiere J. M., Le Moal M. Simon H. (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245, 1511 1513.
38. Piazza P. V., Deminiere M. S., Le Moal M. Simon H. (1990) Individual reactivity to novelty predicts probability of amphetamine self-administration. Behav. Pharmacol. 1, 339 345.
39. Piazza P. V., Rouge-Pont F., Deroche V., Maccari S., Simon H. Le Moal M. (1996) Glucocorticoids have state-dependent stimulant effects on the mecencephalic dopaminergic transmission. Proc. Natl Acad. Sci. USA 93, 8716 8720.
40. 2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 24, 318 325.
41. 5) receptor gene. J. Neurol. Neurosurg. Psychiatry 71, 262 264.
42. 2 receptors. J. Neurosci. 22, 3293 3301.
43. Rostasy K., Augood S. J., Hewett J. W., Leung J. C., Sasaki H., Ozelius L. J., Ramesh V., Standaert D. G., Breakefield X. O. Hedreen J. C. (2003) TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 12, 11 24.
44. Rouge-Pont F., Deroche V., LeMoal M. Piazza P. V. (1998) Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 10, 3903 3907.
45. Rupniak N. M., Jenner P. Marsden C. D. (1986) Acute dystonia unduced by neuroleptic drugs. Psychopharmacology 88, 403 419.
46. Sharma N., Baxter M. G., Petravicz J., Bragg C. D., Schienda A., Standaert D. G. Breakefield X. O. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 5351 5355.
47. Shashidharan P., Sandu D., Potla U., Armata I. A., Walker R. H., McNaught K. S., Weisz D., Sreenath T., Brin M. F. Olanow C. W. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 14, 125 133.
48. Strome E. M., Cepeda I. L., Sossi V. Doudet D. J. (2006) Evaluation of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography. Mol. Imaging. Biol. 8, 292 299.
49. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
50. Torres G. E., Sweeney A. L., Beaulieu J. M., Shashidharan P. Caron M. G. (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant. Proc. Natl Acad. Sci. USA 101, 15650 15655.
51. Wichmann T. (2008) Dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 212, 242 246.
52. Williams J. M. Galli A. (2006) The dopamine transporter: a vigilant border control for psychostimulant action. Handb. Exp. Pharmacol. 175, 215 232.
53. Zhao Y., DeCuypere M. LeDoux M. S. (2008) Abnormal motor function and dopamine neurotransmission in DYT1 deltaGAG transgenic mice. Exp. Neurol. 210, 719 730.